Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29) by 20.69 percent. This is a 11.54 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $57.00 thousand which missed the analyst consensus estimate of $70.00 thousand by 18.57 percent. This is the same as the same period last year.